Stereotaxis stock gains as Erasmus Medical adopts Genesis robotic system, marking a milestone in cardiac arrhythmia care.

Venture capital firm, Genesis Accel, today announced the inaugural Genesis Accel Innovation Summit. Held this year in Pescara, Italy on October 2, this all-day event will bring together experienced ...

BlackRock's BSTZ is a unique, one of a kind technology CEF with a high 11.8% dividend, solid growth, and cutting edge tech ...

Discover how Stereotaxis shifts to high-margin recurring revenue with new products, offering growth potential amid challenges ...

Brightstar Resources has secured approval from the Department of Mines, Petroleum and Exploration (DMPE) for its Lord Byron ...

Big banks are often hailed by their shareholders as strong dividend payers, but new research shows the best dividend stocks of the past decade have come from much different sectors.

On September 24, DS Investment & Securities stated, "The greatest advantage of Hyundai Motor Company's Georgia Meta Plant (HMGMA) in the United States ...

Stereotaxis (STXS) announced the first procedures by physicians at Erasmus University Medical Center in Rotterdam, The Netherlands, using the ...

Reintroducing domestically sourced coal as a back-up fuel for electricity generation during shortages is a pragmatic move ...

Here's today's Connections answer and hints for groups. These clues will help you solve New York Times' popular puzzle game, ...

The GPR market is one of the largest single products in the prepaid ecosystem, with an annual load value exceeding $300 billion. Once designed primarily for consumers without access to traditional ...